Research Interests
My NIH-funded research aims to develop non-invasive ways to diagnose and monitor brain tumors after treatment, without the need for a surgical procedure, by leveraging omics platforms. I am also interested in how radiation therapy can be safely combined with novel systemic therapies, such as immunotherapy, to improve the effectiveness of our treatment while minimizing potential long-term side effects. I am an active participant in clinical trials through the Department of Radiation Oncology, the Duke Center for Brain and Spine Metastasis, and the Preston Robert Tisch Brain Tumor Center at Duke. Our hope is that these studies yield discoveries that improve the effectiveness of our treatments and the quality of life of our patients.
Global Scholarship:
I serve on The Lancet Commission on Neurorehabilitation as a Commissioner in the working group on Neurorehabilitation in Neuro-Oncology. This initiative, led by the World Health Organization (WHO), aims to develop evidence-based pragmatic solutions to improve neurorehabilitation services worldwide, with a focus on overcoming barriers in existing services and fostering available, accessible, affordable, and effective interventions along the care continuum in diverse settings across the globe. (Location: Geneva, Switzerland)
Selected Grants
Elucidating Brain Tumor Biology and Response to Radiotherapy Using Cell-Free-DNA Methylation Signatures
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2024 - 2026Fellowships, Gifts, and Supported Research
External Relationships
- American Society for Radiation Oncology
- Glasshouse Health
- Servier Pharmaceuticals
- Vaios Healthcare Consulting, LLC
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.